U.S. Markets closed

Biogen says it will not give up on Alzheimer’s after failed trials

Sarah Toy
Biogen says it will not give up on Alzheimer’s after failed trials

Biogen Inc. executives sought on Wednesday to ease investors’ concerns over the recent failure of one of the company’s investigational Alzheimer's drugs.